Fortress Biotech, Inc.
NASDAQ:FBIO
Overview | Financials
Company Name | Fortress Biotech, Inc. |
Symbol | FBIO |
Currency | USD |
Price | 2.08 |
Market Cap | 57,418,192 |
Dividend Yield | 0% |
52-week-range | 1.36 - 2.89 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Lindsay Allan Rosenwald |
Website | https://www.fortressbiotech.com |
An error occurred while fetching data.
About Fortress Biotech, Inc.
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD